Search

Scott R. Kastler

Examiner (ID: 3419, Phone: (571)272-1243 , Office: P/1733 )

Most Active Art Unit
1733
Art Unit(s)
1793, 1101, 1733, 1742, 1311, 2899, 1308
Total Applications
4528
Issued Applications
3615
Pending Applications
164
Abandoned Applications
754

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20656623 [patent_doc_number] => 20260108657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-23 [patent_title] => PHARMACEUTICAL COMPOSITIONS FOR TREATING OSTEOARTHRITIS [patent_app_type] => utility [patent_app_number] => 19/412669 [patent_app_country] => US [patent_app_date] => 2025-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19412669 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/412669
PHARMACEUTICAL COMPOSITIONS FOR TREATING OSTEOARTHRITIS Dec 7, 2025 Issued
Array ( [id] => 20458175 [patent_doc_number] => 20260007595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-08 [patent_title] => EYE DROP FORMULATIONS CONTAINING CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN OR DISCOMFORT [patent_app_type] => utility [patent_app_number] => 19/329207 [patent_app_country] => US [patent_app_date] => 2025-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3612 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19329207 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/329207
EYE DROP FORMULATIONS CONTAINING CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN OR DISCOMFORT Sep 14, 2025 Pending
Array ( [id] => 20401329 [patent_doc_number] => 12491289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Pharmaceutical compositions for treating osteoarthritis [patent_app_type] => utility [patent_app_number] => 19/186434 [patent_app_country] => US [patent_app_date] => 2025-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 1080 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19186434 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/186434
Pharmaceutical compositions for treating osteoarthritis Apr 21, 2025 Issued
Array ( [id] => 20401244 [patent_doc_number] => 12491204 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-09 [patent_title] => Use of oleanolic acid-28-O-beta-D-glucopyranoside in preparation of anti-colitis drug [patent_app_type] => utility [patent_app_number] => 18/978008 [patent_app_country] => US [patent_app_date] => 2024-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 0 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18978008 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/978008
Use of oleanolic acid-28-O-beta-D-glucopyranoside in preparation of anti-colitis drug Dec 11, 2024 Issued
Array ( [id] => 19831036 [patent_doc_number] => 20250082822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-13 [patent_title] => PHARMACEUTICAL COMPOSITIONS FOR TREATING OSTEOARTHRITIS [patent_app_type] => utility [patent_app_number] => 18/960884 [patent_app_country] => US [patent_app_date] => 2024-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5989 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18960884 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/960884
Pharmaceutical compositions for treating osteoarthritis Nov 25, 2024 Issued
Array ( [id] => 19599621 [patent_doc_number] => 20240390501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => COLON-TARGETED ACTIVE AGENT DELIVERY CARRIER AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/792077 [patent_app_country] => US [patent_app_date] => 2024-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18792077 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/792077
Colon-targeted active agent delivery carrier and uses thereof Jul 31, 2024 Issued
Array ( [id] => 19541694 [patent_doc_number] => 20240358730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => PREBIOTIC COMPOSITIONS AND METHODS OF PRODUCTION THEREOF [patent_app_type] => utility [patent_app_number] => 18/765449 [patent_app_country] => US [patent_app_date] => 2024-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765449 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/765449
PREBIOTIC COMPOSITIONS AND METHODS OF PRODUCTION THEREOF Jul 7, 2024 Abandoned
Array ( [id] => 19477379 [patent_doc_number] => 20240325421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS [patent_app_type] => utility [patent_app_number] => 18/740196 [patent_app_country] => US [patent_app_date] => 2024-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12457 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18740196 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/740196
PTEN INHIBITORS FOR TREATMENT AND PREVENTION OF BONE MARROW LOSS Jun 10, 2024 Pending
Array ( [id] => 19462425 [patent_doc_number] => 20240316094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => AEROSOL AND TOPICAL ADMINISTRATION OF A FORMULATION CONTAINING CYCLODEXTRIN, QUERCETIN AND ZINC, IN COMBINATION OR SEPARATELY, TO MITIGATE INFECTION BY ENVELOPED VIRUSES [patent_app_type] => utility [patent_app_number] => 18/680557 [patent_app_country] => US [patent_app_date] => 2024-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2054 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18680557 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/680557
AEROSOL AND TOPICAL ADMINISTRATION OF A FORMULATION CONTAINING CYCLODEXTRIN, QUERCETIN AND ZINC, IN COMBINATION OR SEPARATELY, TO MITIGATE INFECTION BY ENVELOPED VIRUSES May 30, 2024 Pending
Array ( [id] => 20270746 [patent_doc_number] => 12440510 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-14 [patent_title] => Use of chondroitin sulfate for relieving ocular pain [patent_app_type] => utility [patent_app_number] => 18/654457 [patent_app_country] => US [patent_app_date] => 2024-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 0 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654457 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/654457
Use of chondroitin sulfate for relieving ocular pain May 2, 2024 Issued
Array ( [id] => 20437421 [patent_doc_number] => 12508242 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-30 [patent_title] => Compositions and methods for treatment of diabetic neuropathies [patent_app_type] => utility [patent_app_number] => 18/641536 [patent_app_country] => US [patent_app_date] => 2024-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 779 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18641536 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/641536
Compositions and methods for treatment of diabetic neuropathies Apr 21, 2024 Issued
Array ( [id] => 19512067 [patent_doc_number] => 20240343753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => THERAPEUTIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/633908 [patent_app_country] => US [patent_app_date] => 2024-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18633908 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/633908
THERAPEUTIC COMPOUNDS Apr 11, 2024 Pending
Array ( [id] => 19808292 [patent_doc_number] => 12239651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Treatment of hearing loss [patent_app_type] => utility [patent_app_number] => 18/609604 [patent_app_country] => US [patent_app_date] => 2024-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25309 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609604 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/609604
Treatment of hearing loss Mar 18, 2024 Issued
Array ( [id] => 19232151 [patent_doc_number] => 20240189342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => OPHTHALMIC SOLUTIONS [patent_app_type] => utility [patent_app_number] => 18/584219 [patent_app_country] => US [patent_app_date] => 2024-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18584219 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/584219
OPHTHALMIC SOLUTIONS Feb 21, 2024 Abandoned
Array ( [id] => 19641340 [patent_doc_number] => 20240415860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE [patent_app_type] => utility [patent_app_number] => 18/430551 [patent_app_country] => US [patent_app_date] => 2024-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18430551 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/430551
FORMULATIONS AND METHODS FOR TREATING CONDITIONS OF THE EYE Jan 31, 2024 Pending
Array ( [id] => 19187969 [patent_doc_number] => 20240166882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-23 [patent_title] => COLOUR-STABLE PREPARATION OF A MAGNESIUM CHLOROPHYLLIN ALKALI METAL SALT OR ALKALI EARTH METAL SALT FROM NATURAL SOURCES OF CHLOROPHYLL [patent_app_type] => utility [patent_app_number] => 18/423614 [patent_app_country] => US [patent_app_date] => 2024-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16841 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18423614 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/423614
COLOUR-STABLE PREPARATION OF A MAGNESIUM CHLOROPHYLLIN ALKALI METAL SALT OR ALKALI EARTH METAL SALT FROM NATURAL SOURCES OF CHLOROPHYLL Jan 25, 2024 Pending
Array ( [id] => 19343752 [patent_doc_number] => 20240252715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => PHARMACEUTICAL COMPOSITIONS FOR TREATING OSTEOARTHRITIS [patent_app_type] => utility [patent_app_number] => 18/424626 [patent_app_country] => US [patent_app_date] => 2024-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18424626 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/424626
Pharmaceutical compositions for treating osteoarthritis Jan 25, 2024 Issued
Array ( [id] => 19417314 [patent_doc_number] => 20240293437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => METHODS OF SELECTIVELY MODULATING GASTROINTESTINAL MICROBIAL GROWTH [patent_app_type] => utility [patent_app_number] => 18/420540 [patent_app_country] => US [patent_app_date] => 2024-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 98868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18420540 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/420540
Methods of selectively modulating gastrointestinal microbial growth Jan 22, 2024 Issued
Array ( [id] => 19666182 [patent_doc_number] => 12178903 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-12-31 [patent_title] => Liquid composition comprising glucose [patent_app_type] => utility [patent_app_number] => 18/417312 [patent_app_country] => US [patent_app_date] => 2024-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8702 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417312 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/417312
Liquid composition comprising glucose Jan 18, 2024 Issued
Array ( [id] => 19372908 [patent_doc_number] => 12064447 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-08-20 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 18/399599 [patent_app_country] => US [patent_app_date] => 2023-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 7669 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18399599 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/399599
None Dec 27, 2023 Issued
Menu